Making the Switch from Biologics to Biosimilars in IBD: Knowledge Over Skepticism

What to Know Before Switching from Biologics to Biosimilars?Подробнее

IBD: Switching from a Biologic to a BiosimilarПодробнее

Biosimilars for IBD: Making the Transition WebinarПодробнее

Incorporating IBD Biosimilars into Practice: Patient Care and EducationПодробнее

Biosimilars for IBD: When to Start, Switch, or Stay Away?Подробнее

Biosimilars for IBD: To Start, Switch, or Stay Away?Подробнее

IBD Clinical Case: The Process of Switching from a Reference Biologic to a BiosimilarПодробнее

Making the Switch from Biologics to Biosimilars in IBD: Knowledge Over SkepticismПодробнее

Biosimilars for IBD: Start, Switch, or Stay Away?Подробнее

DEBATE: Biosimilar Therapies - Caution, more studies are neededПодробнее

Understanding Biosimilars - For IBD PatientsПодробнее

Biosimilars in IBD: Where Do We Stand Today?Подробнее

Biosimilars and Inflammatory Bowel DiseaseПодробнее

The Current Landscape of Biosimilars in IBDПодробнее

Biologic and Biosimilar Medications for Inflammatory Bowel Disease (IBD)Подробнее

Switching to Biosimilars 2021Подробнее

Biosimilars - Making the switchПодробнее

Understanding biosimilars: what IBD patients & caregivers need to knowПодробнее

The Impact of Switching from a Reference Biologic to a BiosimilarПодробнее